Padilla v. Teva Women's Health, LLC et al
| Yessenia Padilla |
| TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., The Cooper Companies Inc, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, Coopersurgical Inc and Teva Women's Health Inc |
| 1:2021cv00876 |
| March 2, 2021 |
| US District Court for the Northern District of Georgia |
| Atlanta Office |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 3, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Clerk's Certificate of Mailing as to Kathleen M. Rhoads re #19 Order. (tmf) |
| Civil Case Terminated. (tmf) |
Filing 19
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
|
Filing 18
TENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 1/27/21. (aar)
|
| Filing 17 Case transferred in from District of California Northern; Case Number 3:21-cv-01103. Original file certified copy of transfer order and docket sheet received. |
| Filing 16 CONDITIONAL TRANSFER ORDER (CTO9) by the UNITED STATES JUDICIAL PANEL onMULTIDISTRICT LITIGATION TRANSFERRING CASE to the United States District Court for the Northern District of Georgia for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. 1407, MDL No. 2974. (tnS, COURT STAFF) (Filed on 3/1/2021) [Transferred from California Northern on 3/2/2021.] |
| case electronically transferred to Northern District of Georgia. (tnS, COURT STAFF) (Filed on 3/1/2021) [Transferred from California Northern on 3/2/2021.] |
|
Filing 15
ORDER REASSIGNING CASE. Case reassigned using a proportionate, random, and blind system pursuant to General Order No. 44 to Judge James Donato for all further proceedings. Magistrate Judge Laurel Beeler no longer assigned to case, Notice: The assigned judge participates in the Cameras in the Courtroom Pilot Project. See General Order No. 65 and http://cand.uscourts.gov/cameras.. Signed by The Clerk on 2/23/21. (Attachments: #1 Notice of Eligibility for Video Recording)(haS, COURT STAFF) (Filed on 2/23/2021) [Transferred from California Northern on 3/2/2021.]
|
| Filing 14 CLERK'S NOTICE OF IMPENDING REASSIGNMENT TO A U.S. DISTRICT COURT JUDGE: The Clerk of this Court will now randomly reassign this case to a District Judge because either (1) a party has not consented to the jurisdiction of a Magistrate Judge, or (2) time is of the essence in deciding a pending judicial action for which the necessary consents to Magistrate Judge jurisdiction have not been secured. You will be informed by separate notice of the district judge to whom this case is reassigned. ALL HEARING DATES PRESENTLY SCHEDULED BEFORE THE CURRENT MAGISTRATE JUDGE ARE VACATED AND SHOULD BE RE-NOTICED FOR HEARING BEFORE THE JUDGE TO WHOM THIS CASE IS REASSIGNED. This is a text only docket entry; there is no document associated with this notice. (ejkS, COURT STAFF) (Filed on 2/22/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 13 CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC.. (Rhoads, Kathleen) (Filed on 2/22/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 12 CERTIFICATE OF SERVICE filed by CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. of re 10 Case Assigned by Intake, re #11 Initial Case Management Scheduling Order with ADR Deadlines (Rhoads, Kathleen) (Filed on 2/18/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 11 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 5/6/2021. Initial Case Management Conference set for 5/13/2021 at 11:00 AM in San Francisco, Courtroom B, 15th Floor. (jlgS, COURT STAFF) (Filed on 2/16/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 10 Case assigned to Magistrate Judge Laurel Beeler. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 2/26/2021. (bwS, COURT STAFF) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 9 Corporate Disclosure Statement by CooperSurgical, Inc., The Cooper Companies, Inc. identifying Other Affiliate T. Rowe Price Associates, Inc., Other Affiliate Vanguard Group, Inc. for The Cooper Companies, Inc.; Other Affiliate The Cooper Companies, Inc. for CooperSurgical, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 8 Corporate Disclosure Statement by Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC identifying Other Affiliate Teva Pharmaceutical Industries, Ltd. for Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 7 ANSWER to Complaint (Notice of Removal) byThe Cooper Companies, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 6 ANSWER to Complaint (Notice of Removal) byTeva Women's Health, LLC. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 5 ANSWER to Complaint (Notice of Removal) byTeva Women's Health, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 4 ANSWER to Complaint (Notice of Removal) byTeva Pharmaceuticals USA, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 3 ANSWER to Complaint (Notice of Removal) byTeva Branded Pharmaceutical Products R&D, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 2 ANSWER to Complaint (Notice of Removal) byCooperSurgical, Inc.. (Rhoads, Kathleen) (Filed on 2/12/2021) [Transferred from California Northern on 3/2/2021.] |
| Filing 1 JOINT NOTICE OF REMOVAL of Action Under 28 U.S.C. 1441(b)(Diveristy Fraudulent Joinder) Jury Trial Demanded from Alameda County Superior Court. Their case number is RG20084360. (Filing fee $402 receipt number 0971-15572541). Filed by Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., CooperSurgical, Inc., Teva Women's Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc.. (Attachments: #1 Exhibit A to Notice of Removal, #2 Exhibit B to Notice of Removal, #3 Exhibit C to Notice of Removal, #4 Exhibit D to Notice of Removal, #5 Civil Cover Sheet)(Rhoads, Kathleen) (Filed on 2/12/2021) Modified on 2/16/2021 (jlgS, COURT STAFF). [Transferred from California Northern on 3/2/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
